Rising Healthcare Spending And Aging Population Will Expand Biotech Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
01 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$80.00
32.8% undervalued intrinsic discount08 Aug
US$53.74
1Y
-28.3%7D
7.2%